Augmented reality-based sensory interaction device

Augmented reality-based sensory interaction device has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Feb 25, 2026: “Research on the effect of augmented reality based sensory interaction device in rehabilitation training of patients with chronic heart failure”.

Exposure

1 paper studies it3 findingsUpdated

See all 1 papers on augmented reality-based sensory interaction device

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Post-intervention analysis revealed significant improvements in the intervention group across several parameters, including left ventricular ejection fraction (LVEF: 54.11% vs. 51.85%, P < 0.001)”
Research on the effect of augmented reality based sensory interaction device in rehabilitation training of patients with chronic heart failureBMC cardiovascular disorders2026doi:10.1186/s12872-026-05625-y

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Human trial1

What did studies of augmented reality-based sensory interaction device find?

3

Studies of augmented reality-based sensory interaction device measured 3 outcomes: Minnesota Living With Heart Failure Questionnaire score, exercise capacity and left ventricular ejection fraction.

Minnesota Living With Heart Failure Questionnaire score

downin humans1

1 study
  1. Augmented reality-based sensory interaction device decreases Minnesota Living With Heart Failure Questionnaire score in humans (chronic heart failure).

    “MLHFQ scores decreased more substantially, indicating enhanced quality of life.”

    Human trialchronic heart failurefour-weekn = 200

    Research on the effect of augmented reality based sensory interaction device in rehabilitation training of patients with chronic heart failure

    BMC cardiovascular disorders

More on Minnesota Living With Heart Failure Questionnaire score

Exercise capacity

upin humans1

1 study
  1. Augmented reality-based sensory interaction device improves exercise capacity in humans (chronic heart failure) (392.14 m vs. 367.89 m).

    “Exercise capacity, indicated by 6-minute walking distance (6MWD: 392.14 m vs. 367.89 m, P < 0.001), and GSES scores also improved significantly (25.14 vs. 23.82, P = 0.009).”

    Human trialchronic heart failurefour-weekn = 200

    Research on the effect of augmented reality based sensory interaction device in rehabilitation training of patients with chronic heart failure

    BMC cardiovascular disorders

Left ventricular ejection fraction

upin humans1

1 study
  1. Augmented reality-based sensory interaction device improves left ventricular ejection fraction in humans (chronic heart failure) (54.11% vs. 51.85%).

    “Post-intervention analysis revealed significant improvements in the intervention group across several parameters, including left ventricular ejection fraction (LVEF: 54.11% vs. 51.85%, P < 0.001)”

    Human trialchronic heart failurefour-weekn = 200

    Research on the effect of augmented reality based sensory interaction device in rehabilitation training of patients with chronic heart failure

    BMC cardiovascular disorders

More on Left ventricular ejection fraction

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months